TCM Biotech International PEG Ratio

The latest PEG ratio for 4169.TWO is 537.22. That is above the Healthcare sector average of 27.75. Investors often review this figure alongside TCM Biotech International's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, 4169.TWO currently prints 537.22 for PEG ratio, while the sector average sits near 27.75. That is roughly 1835.8% above the sector mean. Large gaps often invite a closer look at TCM Biotech International's growth, margins, and balance sheet.

A PEG ratio of 537.22 for TCM Biotech International is not 'good' or 'bad' on its own. Compare it with the peer average (27.75) and with 4169.TWO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting 4169.TWO's PEG ratio (537.22), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack TCM Biotech International's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.